Nelipak Expands APAC Footprint with New Technical Development Center

Nelipak's opening of its new Technical Development Center (TDC) in the Asia-Pacific region marks a significant milestone in the company's global expansion strategy. By establishing a dedicated technical hub in one of the world's fastest-growing medical device markets, Nelipak is positioning itself to better serve regional customers who previously relied on design and prototyping services from North America or Europe. This localized approach is not just about proximity; it is a strategic response to the increasing complexity of medical packaging regulations and the need for rapid iteration in the product development lifecycle. The facility is expected to serve as a critical link between initial concept and final production, offering specialized engineering expertise that is often a bottleneck in the medical device supply chain.

The Asia-Pacific medical device market is projected to grow at a compound annual growth rate (CAGR) of over 6% through 2030, driven by aging populations and increased healthcare spending in China, India, and Southeast Asia. However, the supply chain for these critical products has historically faced challenges related to long lead times for specialized packaging. Nelipak’s new center addresses this by offering end-to-end services, including package design, prototyping, and performance testing, all within the regional time zone and regulatory context. This allows for real-time collaboration between Nelipak's engineers and the R&D teams of major medical device original equipment manufacturers (OEMs) based in the region.

“

The Asia-Pacific medical device market is projected to grow at a compound annual growth rate (CAGR) of over 6% through 2030, driven by aging populations and increased healthcare spending in China, India, and Southeast Asia.

From a logistics and supply chain perspective, the TDC significantly reduces the "design-to-delivery" cycle. In the medical device industry, packaging is not an afterthought; it is a critical component of the sterile barrier system. By performing testing and validation locally, manufacturers can identify potential failures earlier in the process, avoiding costly delays in clinical trials or commercial launches. Furthermore, this move aligns with broader industry trends toward regionalization—the strategy of building supply chain capabilities closer to the point of consumption to mitigate the risks of global disruptions that have plagued the industry in recent years. By shortening the feedback loop, Nelipak is effectively de-risking the product launch process for its clients.